We examined the effects of Lactobacillus rhamnosus HN001 on eczema prevention among children with genetic predispositions. In our double-blind, randomized, placebo-controlled study involving 331 children, we discovered that those with specific high-risk gene variants experienced lower eczema rates when treated with HN001, compared to those receiving a placebo. This suggests Lactobacillus rhamnosus might be particularly beneficial for children at greater genetic risk of eczema and may even influence the severity of eczema and related allergic conditions.
Read More
2
Lactobacillus rhamnosus ineffective for eczema
Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial.
We investigated whether taking the probiotic Lactobacillus rhamnosus GG during pregnancy could help lower the risk of eczema in infants. In a randomized controlled trial, 250 pregnant women, whose babies were at high risk for allergic diseases, took this probiotic from 36 weeks until delivery.
Unfortunately, we found that this prenatal treatment didn’t significantly reduce the incidence of eczema or any allergic reactions in their babies. This suggests that probiotics might need to be given after birth, or we may need to explore different strains for better results.
Read More
9
Probiotic reduces eczema prevalence
Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
We explored the potential of Lactobacillus rhamnosus HN001 in reducing eczema among infants at high risk. Through a robust double-blind trial, expecting mothers took the probiotic from 35 weeks pregnant and continued while breastfeeding, while infants received it from birth to two years. Remarkably, this approach halved the prevalence of eczema by ages 2 and 4. Even better, the benefits seemed to last until age 6, showing promising potential in preventing eczema and associated allergic sensitization. However, another probiotic, HN019, did not show similar effects, suggesting specific benefits tied to HN001.
Read More
Most Useful Reviews
7.5
Significant improvement noticed
3 people found this helpful
My eczema has shown considerable improvement after years of struggle. Through consultations with nutritionists, I learned that probiotics could positively influence eczema. Initially, I bought two boxes and now only consume one box. Nearly a decade of eczema has significantly improved, and I plan to continue.
Read More
9
Cured eczema quickly
I’ve purchased this probiotic repeatedly as it helped cure my eczema and abdominal pain. Despite not following the package instructions precisely and doubling the daily dosage, my facial eczema cleared up in under a week. I've also recommended it to three friends who, after seeing a doctor for a week with no improvement, noticed significant betterment after just one day of using this probiotic. I highly endorse this brand.
Read More
6
Helps with skin condition
I regularly consume probiotics, which are beneficial for eczema-prone skin. The doctor mentioned that I have a lazy bowel, and I've noticed they help alleviate gas after meals.
We conducted a study to see if giving probiotics to mothers during pregnancy and breastfeeding could help reduce eczema in infants at risk. This double-blind, placebo-controlled trial involved 241 mother-infant pairs, where mothers were given either specific probiotics or a placebo.
Our findings showed that infants whose mothers took Lactobacillus rhamnosus and Bifidobacterium longum had a significantly lower risk of developing eczema in their first two years. This suggests that probiotics can be a safe and effective preventive measure for high-risk infants.
Read More
9
Probiotic reduces eczema prevalence
Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
We explored the potential of Lactobacillus rhamnosus HN001 in reducing eczema among infants at high risk. Through a robust double-blind trial, expecting mothers took the probiotic from 35 weeks pregnant and continued while breastfeeding, while infants received it from birth to two years. Remarkably, this approach halved the prevalence of eczema by ages 2 and 4. Even better, the benefits seemed to last until age 6, showing promising potential in preventing eczema and associated allergic sensitization. However, another probiotic, HN019, did not show similar effects, suggesting specific benefits tied to HN001.
Read More
9
Lactobacillus rhamnosus reduces eczema prevalence
A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years.
We conducted a robust study using a double-blind randomized placebo-controlled trial to explore the impact of Lactobacillus rhamnosus HN001 on eczema in young children.
Mothers supplemented with HN001 from the 35th week of pregnancy until 6 months of breastfeeding, while infants continued taking the probiotic until age 2.
Remarkably, we found that this approach halved the prevalence of eczema by age 2, and its protective effects persisted up to age 4. HN001 may be a promising preventive measure for infants at high risk of allergic diseases.
Read More
8
Probiotic formula benefits allergy management
The Impact of Formula Choice for the Management of Pediatric Cow's Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort Study.
We examined the impact of several infant formulas on allergies in children with cow's milk allergy over 36 months.
Our findings showed that the extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG led to a significantly lower rate of eczema and other allergic issues compared to other formula types.
Children treated with this particular formula also exhibited a faster development of immune tolerance.
It appears that incorporating this probiotic could be beneficial for managing allergies in infants.
Read More
8
Probiotics reduce eczema incidence
Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial.
In a double-blind, placebo-controlled trial, we evaluated the effect of Lactobacillus rhamnosus alongside Bifidobacterium on eczema development in infants.
Over 290 participants received either the probiotic mixture or a placebo. Notably, at the end of the six-month intervention, only 4.2% of the probiotic group developed eczema, compared to 11.5% in the placebo group.
Other allergic conditions like asthma and rhinitis showed no significant differences, indicating that while probiotics may help with eczema, they don’t necessarily prevent other common allergies.
My eczema has shown considerable improvement after years of struggle. Through consultations with nutritionists, I learned that probiotics could positively influence eczema. Initially, I bought two boxes and now only consume one box. Nearly a decade of eczema has significantly improved, and I plan to continue.
Read More
9
Cured eczema quickly
I’ve purchased this probiotic repeatedly as it helped cure my eczema and abdominal pain. Despite not following the package instructions precisely and doubling the daily dosage, my facial eczema cleared up in under a week. I've also recommended it to three friends who, after seeing a doctor for a week with no improvement, noticed significant betterment after just one day of using this probiotic. I highly endorse this brand.
Read More
6
Helps with skin condition
I regularly consume probiotics, which are beneficial for eczema-prone skin. The doctor mentioned that I have a lazy bowel, and I've noticed they help alleviate gas after meals.
Read More
7.5
Helpful for eczema
Very good! I keep repurchasing probiotics, which assist my eczema. The doctor remarked on my lethargy, but I find they help after meals. If any issue arises, I consume them first.
Read More
Frequently Asked Questions
Eczema, also known as atopic dermatitis, is a chronic skin condition characterized by inflamed, itchy, and red patches on the skin. It is most commonly seen in children but can occur at any age. The condition can range from mild to severe and often leads to dry, scaly skin that can become cracked or even bleed. Eczema is believed to be related to a combination of genetic predisposition, skin barrier dysfunction, and environmental factors, including allergens, irritants, and stress.
Treatment for eczema often involves a multi-faceted approach, including the use of moisturizers to keep the skin hydrated, topical corticosteroids to reduce inflammation, and, in some cases, antihistamines to alleviate itching. Identifying and avoiding triggers such as certain soaps, fabrics, or foods can also play a crucial role in managing the condition. While there is currently no cure for eczema, ongoing advancements in research have led to the development of new therapies, including biologic medications that target specific components of the immune response, offering hope for those with moderate to severe cases.
Lactobacillus is a genus of bacteria that plays a crucial role in the fermentation of various foods and is found naturally in the human gut. Known for their probiotic properties, strains of Lactobacillus are commonly utilized in the production of yogurt, sauerkraut, and other fermented products. They are characterized by their rod-shaped structure and ability to convert sugars into lactic acid, which not only helps preserve food but also contributes to the tangy flavor of fermented foods.
In addition to their culinary uses, Lactobacillus bacteria can offer several health benefits. They are known to support gut health by enhancing the balance of beneficial bacteria in the microbiome, potentially aiding in digestion and alleviating symptoms of issues like irritable bowel syndrome (IBS). Regular consumption of Lactobacillus-containing foods or supplements may also bolster the immune system and improve overall digestive health. With a growing interest in gut health, Lactobacillus remains a key player in both dietary and therapeutic contexts.
Lactobacillus, a genus of beneficial bacteria commonly found in probiotic supplements and fermented foods, has shown promise in being helpful for some individuals with eczema. Research indicates that probiotics may contribute to skin health by helping to enhance the skin's barrier function, reducing inflammation, and positively influencing the immune system. Some studies have indicated that specific strains of Lactobacillus can reduce the severity of eczema symptoms, especially in infants and children who are prone to allergic skin conditions.
However, while the results of these studies are encouraging, it is important to note that not all probiotics are equally effective for eczema, and individual responses can vary. Consulting with a healthcare professional is crucial before adding any new treatments or supplements to your routine, particularly for susceptible populations. As ongoing research continues to explore the relationship between gut health, immune function, and skin conditions like eczema, it’s essential to consider a holistic approach, including lifestyle adjustments, diet, and professional medical advice for managing eczema effectively.
Based on user reviews, the time it takes to see results from this probiotic supplement for eczema varies significantly among individuals. Some users report substantial improvements in their eczema symptoms within just a few days. For instance, one user noted that their facial eczema cleared up in under a week, even after not following the dosage instructions precisely Read Review. Another user mentioned considerable improvements after nearly a decade of struggles, highlighting an overall positive shift in their condition Read Review.
However, it is essential to recognize that the timeline for seeing results can differ greatly based on individual circumstances and adherence to the supplement regimen. While some may experience quick relief, others might need to take the probiotics consistently over a prolonged period before noticing significant changes in their eczema conditions. Overall, patience and consistency appear to be key components in achieving potential improvements.
Scientific research suggests that Lactobacillus rhamnosus, particularly certain strains like HN001, may play a beneficial role in reducing the risk of eczema, especially in infants at high risk. Studies have shown that administering this probiotic during pregnancy and breastfeeding, as well as directly to infants, significantly halved the prevalence of eczema by age two, with potential long-term benefits lasting into early childhood [12]. A double-blind trial indicated that infants receiving the probiotic had a notably lower rate of eczema development compared to those given a placebo, with a 50% reduction in risk noted in research involving over 474 participants [4].
While the findings are promising, it's important to note that not all studies have reached consistent conclusions, and some trials suggest that maternal supplementation alone may not yield significant effects [7]. Additionally, the specific strains and timing of supplementation appear to be crucial factors in their efficacy [13]. Therefore, while Lactobacillus rhamnosus is supported by scientific evidence as a potentially effective approach to managing eczema through early intervention, further research is warranted to fully understand the long-lasting effects and optimal administration methods.
Users have reported a range of improvements in their eczema symptoms after using this probiotic supplement. For some, the results have been impressive and rapid; one reviewer mentioned their facial eczema cleared up in under a week, even after not following the dosage instructions exactly Read Review. Another user, who had struggled for nearly a decade, experienced considerable improvement after incorporating the probiotics into their routine, emphasizing the positive change in their skin condition Read Review.
Additionally, consistent usage of probiotics seems to contribute to an overall betterment in gastrointestinal symptoms, which may indirectly help with skin health. One user noted benefits in alleviating gas-related discomfort after meals, linking their positive experience to the regular consumption of probiotics Read Review. While individual results certainly vary, many users express satisfaction and continued use of the product, emphasizing its role as a beneficial component of their eczema management routine.
Users have reported various experiences when combining this probiotic supplement with other supplements or dietary changes to manage their eczema. One user, after years of struggling with eczema, found that consulting with nutritionists suggested probiotics could have a positive impact on their condition, leading to considerable improvement Read Review. Another reviewer highlighted that they have noticed significant benefits not only for their skin but also for digestive health, stating that probiotics helped alleviate gas and abdominal discomfort, which may play a role in overall wellness Read Review.
Several users expressed their strong endorsement of the product, often repurchasing it due to its beneficial effects on eczema. One user, despite deviating from the dosing recommendations, saw rapid improvement in their facial eczema, suggesting that the probiotic may work effectively even when combined with less strict adherence to dosage Read Review. Others echoed similar sentiments, indicating a positive correlation between regular probiotic intake and improvements in their skin, combined with overall digestive health benefits Read Review. This points to a potential synergy when managing eczema alongside dietary or supplement modifications.
When it comes to dosing Lactobacillus rhamnosus for treating eczema, recent research points towards a structured approach that includes both prenatal and postnatal supplementation. Specifically, studies indicate that pregnant women taking Lactobacillus rhamnosus HN001 from around the 35th week of pregnancy, followed by continued supplementation in their infants until the age of two, can significantly reduce the prevalence of eczema. The findings suggest that this regimen halved the eczema occurrence by ages two and four and maintained benefits as the child grew [12].
Furthermore, it seems that dosing should not only focus on the quantity but also on timing and the specific strain used. While the exact optimal dose in milligrams or CFUs (colony-forming units) isn't explicitly defined in the research, the combination of maternal and infant intake appears crucial. It's advisable to consult with healthcare providers to tailor the dosage based on individual needs and to ensure safety and efficacy for both the mother and the infant [14]. Overall, this approach shows promise in establishing Lactobacillus as a key player in managing and preventing eczema in at-risk populations.
9
Cured eczema quickly
I’ve purchased this probiotic repeatedly as it helped cure my eczema and abdominal pain. Despite not following the package instructions precisely and doubling the daily dosage, my facial eczema cleared up in under a week. I've also recommended it to three friends who, after seeing a doctor for a week with no improvement, noticed significant betterment after just one day of using this probiotic. I highly endorse this brand.
7.5
Significant improvement noticed
3 people found this helpful
My eczema has shown considerable improvement after years of struggle. Through consultations with nutritionists, I learned that probiotics could positively influence eczema. Initially, I bought two boxes and now only consume one box. Nearly a decade of eczema has significantly improved, and I plan to continue.
6
Helps with skin condition
I regularly consume probiotics, which are beneficial for eczema-prone skin. The doctor mentioned that I have a lazy bowel, and I've noticed they help alleviate gas after meals.
7.5
Helpful for eczema
Very good! I keep repurchasing probiotics, which assist my eczema. The doctor remarked on my lethargy, but I find they help after meals. If any issue arises, I consume them first.
9
Probiotic reduces eczema prevalence
Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
We explored the potential of Lactobacillus rhamnosus HN001 in reducing eczema among infants at high risk. Through a robust double-blind trial, expecting mothers took the probiotic from 35 weeks pregnant and continued while breastfeeding, while infants received it from birth to two years. Remarkably, this approach halved the prevalence of eczema by ages 2 and 4. Even better, the benefits seemed to last until age 6, showing promising potential in preventing eczema and associated allergic sensitization. However, another probiotic, HN019, did not show similar effects, suggesting specific benefits tied to HN001.
8
Lactobacillus rhamnosus reduces eczema risk
Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
We investigated how the probiotic Lactobacillus rhamnosus HN001 affects eczema in infants. In a well-structured study involving 474 infants, those who received the probiotic had a 50% lower risk of developing eczema compared to a placebo group.
Interestingly, while the probiotic did increase the functional capacity of the gut microbiome, it didn’t significantly change its overall composition. This study suggests that Lactobacillus rhamnosus HN001 can be a beneficial factor in reducing eczema risk, but more research is needed to understand how these changes relate to long-term health.
2
Lactobacillus Rhamnosus alone ineffective
Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema.
We conducted a randomized placebo-controlled trial to evaluate whether maternal supplementation with the probiotic Lactobacillus rhamnosus HN001 could reduce the risk of infant eczema. Mothers took the probiotic from 14 to 16 weeks of pregnancy until 6 months after birth while breastfeeding, but the infants didn’t receive the probiotic directly.
Unfortunately, our findings showed that this approach did not significantly reduce eczema or related conditions by the time the children reached 12 months old. This contrasts with previous research where both mothers and infants took the supplement and saw better results.
8
Eczema prevention linked to probiotics
Probiotics and prebiotics in preventing food allergy and eczema.
We explored the effectiveness of probiotics, particularly Lactobacillus rhamnosus, in preventing eczema and food allergies. The research highlights that combining prenatal and postnatal probiotic treatment can significantly reduce eczema prevalence in infants up to 2 years old, with some benefits lasting until age 4. However, not all studies are consistent—while many show promising results, others do not find any significant effects. This suggests that the timing and specific strain of probiotics play a crucial role in their potential benefits.
9.5
Probiotic benefits for at-risk infants
Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant.
We conducted a study to see if giving probiotics to mothers during pregnancy and breastfeeding could help reduce eczema in infants at risk. This double-blind, placebo-controlled trial involved 241 mother-infant pairs, where mothers were given either specific probiotics or a placebo.
Our findings showed that infants whose mothers took Lactobacillus rhamnosus and Bifidobacterium longum had a significantly lower risk of developing eczema in their first two years. This suggests that probiotics can be a safe and effective preventive measure for high-risk infants.
References
Voigt J, Lele M. Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials. Am J Clin Dermatol. 2022;23:801. doi:10.1007/s40257-022-00723-x
Nocerino R, Bedogni G, Carucci L, Cosenza L, Cozzolino T, et al. The Impact of Formula Choice for the Management of Pediatric Cow's Milk Allergy on the Occurrence of Other Allergic Manifestations: The Atopic March Cohort Study. J Pediatr. 2021;232:183. doi:10.1016/j.jpeds.2021.01.059
Schmidt RM, Pilmann Laursen R, Bruun S, Larnkjaer A, Mølgaard C, et al. Probiotics in late infancy reduce the incidence of eczema: A randomized controlled trial. Pediatr Allergy Immunol. 2019;30:335. doi:10.1111/pai.13018
Murphy R, Morgan XC, Wang XY, Wickens K, Purdie G, et al. Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT. Benef Microbes. 2019;10:5. doi:10.3920/BM2017.0191
Wickens K, Barthow C, Mitchell EA, Kang J, van Zyl N, et al. Effects of Lactobacillus rhamnosus HN001 in early life on the cumulative prevalence of allergic disease to 11 years. Pediatr Allergy Immunol. 2018;29:808. doi:10.1111/pai.12982
Gulliver WP, Hutton AS, Ship N. Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis. Clin Cosmet Investig Dermatol. 2018;11:265. doi:10.2147/CCID.S164748
Wickens K, Barthow C, Mitchell EA, Stanley TV, Purdie G, et al. Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema. Pediatr Allergy Immunol. 2018;29:296. doi:10.1111/pai.12874
Berni Canani R, Di Costanzo M, Bedogni G, Amoroso A, Cosenza L, et al. Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial. J Allergy Clin Immunol. 2017;139:1906. doi:10.1016/j.jaci.2016.10.050
Marlow G, Han DY, Wickens K, Stanley T, Crane J, et al. Differential effects of two probiotics on the risks of eczema and atopy associated with single nucleotide polymorphisms to Toll-like receptors. Pediatr Allergy Immunol. 2015;26:262. doi:10.1111/pai.12371
Ismail IH, Boyle RJ, Mah LJ, Licciardi PV, Tang ML. Reduced neonatal regulatory T cell response to microbial stimuli associates with subsequent eczema in high-risk infants. Pediatr Allergy Immunol. 2014;25:674. doi:10.1111/pai.12303
Morgan AR, Han DY, Wickens K, Barthow C, Mitchell EA, et al. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy. 2014;44:1255. doi:10.1111/cea.12394
Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?. Clin Exp Allergy. 2013;43:1048. doi:10.1111/cea.12154
Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol. 2013;13:280. doi:10.1097/ACI.0b013e328360ed66
Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol. 2012;130:1355. doi:10.1016/j.jaci.2012.09.003
Wickens K, Black P, Stanley TV, Mitchell E, Barthow C, et al. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy. 2012;42:1071. doi:10.1111/j.1365-2222.2012.03975.x
Boyle RJ, Ismail IH, Kivivuori S, Licciardi PV, Robins-Browne RM, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy. 2011;66:509. doi:10.1111/j.1398-9995.2010.02507.x